Atlas Trials

Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC

Clinical trial NCT02047344 · COMPLETED

Trial details

NCT number
NCT02047344
Sponsor
Golden Biotechnology Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer Stage IV
Start date
2013-10-01
Primary completion
2018-12-07
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.